XML 13 R2.htm IDEA: XBRL DOCUMENT v3.5.0.2
Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
Sep. 30, 2016
Jun. 30, 2016
Series B Preferred Stock [Member]    
Current liabilities:    
Series B Redeemable Convertible Preferred stock, $0.01 par value, 50,000 shares authorized; 200 shares issued and outstanding, liquidation preference of $30,500 and $30,000, respectively (Note 7) $ 27,900 $ 27,400
Series A Preferred Stock [Member]    
Deficit:    
Preferred stock, value 0 0
Series C Preferred Stock [Member]    
Deficit:    
Preferred stock, value 0 0
Cash 64,418 170,194
Prepaid expenses 15,901 15,240
Subscription receivable 7,500
Deposits and other receivables 1,000 1,000
Total current assets 81,319 193,934
Property and equipment, net (Note 3) 3,757 4,259
Total assets 85,076 198,193
Accounts payable and accrued expenses 818,133 768,272
Deferred compensation (Note 4) 1,657,541 1,436,595
Loan payable and accrued interest (Note 5) 8,621,827 8,563,662
Total current liabilities 11,125,401 10,795,929
Convertible notes payable - affiliates (Note 6) 3,311,988 3,280,647
Total liabilities 14,437,389 14,076,576
Common stock, no par value, 100,000,000 shares authorized, 23,761,168 and 23,573,057 shares issued, respectively; 23,056,859 and 22,868,748 shares outstanding, respectively 0 0
Additional paid-in capital 102,434,634 102,278,364
Accumulated deficit (116,846,159) (116,216,493)
Total Bion's stockholders’ deficit (14,411,525) (13,938,129)
Noncontrolling interest 59,212 59,746
Total deficit (14,352,313) (13,878,383)
Total liabilities and deficit $ 85,076 $ 198,193